Found 73 matching trials
OPT-CAD Score GUIded Dual ANtiplatelet De-esCalation Time NA Monotherapy with a P2Y12 inhibitor after a minimum period of DAPT following...
Show More Location
General Hospital of Northern Theater Command
Learn More & Join Trial
Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy NA The study aims to evaluate a modified antiplatelet therapy associated with ...
Show More Location
Universitätsklinikum
Learn More & Join Trial
XIENCE 28 USA Study NA The XIENCE 28 USA Study is prospective, single arm, multi-center, open labe...
Show More Location
Heart Center Research, LLC
Learn More & Join Trial
EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events PHASE4 EDUCATE is a prospective, multi-center study designed to collect real-world...
Show More Location
AnMed Health Medical Center
Learn More & Join Trial
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) PHASE4 This study is a prospective, multicenter, parallel, open-label, randomized,...
Show More Location
Xinqiao Hospital, Army Medical University
Learn More & Join Trial
EluNIR Ridaforolimus Eluting Coronary Stent System in Patients at High Bleeding Risk (HBR)- EluNIR HBR Study N/A The study will enroll approximately 316 subjects with a wide spectrum of PC...
Show More Learn More & Join Trial
Plasma and Platelet microRNAs in Clopidogrel Low Response Patients PHASE4 Clopidogrel is an important anti-platelet agent.However, about 30% of the c...
Show More Location
First Affiliated Hospital of Nanjing Medical University
Learn More & Join Trial
Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy N/A Study Purpose Coronary heart disease (CAD) is a leading global cause of dea...
Show More Location
General Hospital of Northern Theater Command
Learn More & Join Trial
Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI PHASE3 The goal of this clinical trial is to learn if reducing the duration of dua...
Show More Location
Caen University Hospital
Learn More & Join Trial
XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients. NA XIENCE 90 study is a prospective, single arm, multi-center, open label tria...
Show More Location
Huntsville Hospital (Heart Center Research LLC)
Learn More & Join Trial